Package 0067-2040-09

{"route": ["ORAL"], "spl_id": "cc2a55d5-3c7f-4c59-a38a-cb51e693649d", "openfda": {"nui": ["N0000000160", "N0000008836", "M0001335", "N0000175722", "N0000175578", "N0000008832", "N0000175739", "N0000175729", "N0000175790", "M0023046"], "unii": ["362O9ITL9D", "R16CO5Y76E", "3G6A5W338E"], "rxcui": ["209468", "308297"], "spl_set_id": ["910d7254-d0f4-4c5c-a26e-7f8acecbe02d"], "pharm_class_cs": ["Anti-Inflammatory Agents, Non-Steroidal [CS]", "Xanthines [CS]"], "pharm_class_pe": ["Decreased Prostaglandin Production [PE]", "Decreased Platelet Aggregation [PE]", "Central Nervous System Stimulation [PE]"], "pharm_class_epc": ["Nonsteroidal Anti-inflammatory Drug [EPC]", "Platelet Aggregation Inhibitor [EPC]", "Central Nervous System Stimulant [EPC]", "Methylxanthine [EPC]"], "pharm_class_moa": ["Cyclooxygenase Inhibitors [MoA]"], "manufacturer_name": ["Haleon US Holdings LLC"], "is_original_packager": [true]}, "finished": true, "packaging": [{"sample": false, "description": "2 TABLET, FILM COATED in 1 POUCH (0067-2040-01)", "package_ndc": "0067-2040-01", "marketing_start_date": "20210131"}, {"sample": false, "description": "1 BOTTLE in 1 CARTON (0067-2040-02)  / 24 TABLET, FILM COATED in 1 BOTTLE", "package_ndc": "0067-2040-02", "marketing_start_date": "20200930"}, {"sample": false, "description": "1 BOTTLE in 1 CARTON (0067-2040-03)  / 30 TABLET, FILM COATED in 1 BOTTLE", "package_ndc": "0067-2040-03", "marketing_start_date": "20200930"}, {"sample": false, "description": "1 BOTTLE in 1 CARTON (0067-2040-04)  / 50 TABLET, FILM COATED in 1 BOTTLE", "package_ndc": "0067-2040-04", "marketing_start_date": "20200930"}, {"sample": false, "description": "1 BOTTLE in 1 CARTON (0067-2040-05)  / 100 TABLET, FILM COATED in 1 BOTTLE", "package_ndc": "0067-2040-05", "marketing_start_date": "20200930"}, {"sample": false, "description": "1 BOTTLE in 1 CARTON (0067-2040-06)  / 125 TABLET, FILM COATED in 1 BOTTLE", "package_ndc": "0067-2040-06", "marketing_start_date": "20200930"}, {"sample": false, "description": "1 BOTTLE in 1 CARTON (0067-2040-07)  / 200 TABLET, FILM COATED in 1 BOTTLE", "package_ndc": "0067-2040-07", "marketing_start_date": "20200930"}, {"sample": false, "description": "1 BOTTLE in 1 CARTON (0067-2040-08)  / 250 TABLET, FILM COATED in 1 BOTTLE", "package_ndc": "0067-2040-08", "marketing_start_date": "20200930"}, {"sample": false, "description": "1 BOTTLE in 1 CARTON (0067-2040-09)  / 300 TABLET, FILM COATED in 1 BOTTLE", "package_ndc": "0067-2040-09", "marketing_start_date": "20200930"}, {"sample": false, "description": "1 VIAL in 1 PACKAGE (0067-2040-11)  / 8 TABLET, FILM COATED in 1 VIAL", "package_ndc": "0067-2040-11", "marketing_start_date": "20230306"}], "brand_name": "Excedrin Migraine", "product_id": "0067-2040_cc2a55d5-3c7f-4c59-a38a-cb51e693649d", "dosage_form": "TABLET, FILM COATED", "pharm_class": ["Anti-Inflammatory Agents", "Non-Steroidal [CS]", "Central Nervous System Stimulant [EPC]", "Central Nervous System Stimulation [PE]", "Cyclooxygenase Inhibitors [MoA]", "Decreased Platelet Aggregation [PE]", "Decreased Prostaglandin Production [PE]", "Methylxanthine [EPC]", "Nonsteroidal Anti-inflammatory Drug [EPC]", "Platelet Aggregation Inhibitor [EPC]", "Xanthines [CS]"], "product_ndc": "0067-2040", "generic_name": "Acetaminophen, Aspirin, and Caffeine", "labeler_name": "Haleon US Holdings LLC", "product_type": "HUMAN OTC DRUG", "brand_name_base": "Excedrin", "brand_name_suffix": "Migraine", "active_ingredients": [{"name": "ACETAMINOPHEN", "strength": "250 mg/1"}, {"name": "ASPIRIN", "strength": "250 mg/1"}, {"name": "CAFFEINE", "strength": "65 mg/1"}], "application_number": "NDA020802", "marketing_category": "NDA", "marketing_start_date": "20200930", "listing_expiration_date": "20261231"}